Gender dependency in the pathogenesis of cardiac hypertrophy: Effect of norepinephrine on transforming growth factor-β release in female heart

Hypertension

Volumn 44, Issue 4, 2004, Pages 392-393

  Dixon, Ian M C ^a,b   Drobic, Vanja ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NORADRENALIN; TRANSFORMING GROWTH FACTOR BETA;

CELL DIFFERENTIATION; CELL GROWTH; EDITORIAL; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SEX DIFFERENCE;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; CARDIOMEGALY; FEMALE; HEART; HUMANS; MYOCARDIUM; NOREPINEPHRINE; TRANSFORMING GROWTH FACTOR BETA;

EID: 4644353446     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000141484.53649.6f     Document Type: Editorial

References (27)

1. Weber KT. Fibrosis, a common pathway to organ failure: angiotensin II and tissue repair. Semin Nephrol. 1997;17:467-491.
2. Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol. 2003;200:500-503.
3. Peterson DJ, Ju H, Hao J, Panagia M, Chapman DC, Dixon IM. Expression of Gi-2 alpha and Gs alpha in myofibroblasts localized to the infarct scar in heart failure due to myocardial infarction. Cardiovasc Res. 1999;41:575-585.
4. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002;53:31-47.
5. Schlaich MP, Kaye DM, Lambert E, Sommerville M, Socratous F, Esler MD. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation. 2003;108:560-565.
6. Ahmed A. Myocardial beta-1 adrenoceptor down-regulation in aging and heart failure: implications for beta-blocker use in older adults with heart failure. Eur J Heart Fail. 2003;5:709-715.
7. Ju H, Zhao S, Davinder SJ, Dixon IM. Effect of ATI receptor blockade on cardiac collagen remodeling after myocardial infarction. Cardiovasc Res. 1997;35:223-232.
8. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res. 1985;57:84-95.
9. Jugdutt BI. Effect of captopril and enalapril on left ventricular geometry, function and collagen during healing after anterior and inferior myocardial infarction in a dog model. J Am Coll Cardiol. 1995;25:1718-1725.
10. Butt RP, Laurent GJ, Bishop JE. Collagen production and replication by cardiac fibroblasts is enhanced in response to diverse classes of growth factors. Eur J Cell Biol. 1995;68:330-335.
11. Silber DH. Heart failure in women. Curr Womens Health Rep. 2003;3:104-109.
12. Briest W, Homagk L, Rabler B, Zeigelhoffer-Mihalovicova B, Meier H, Tannapfel A, Leiblein S, Saalbach A, Deten A, Zimmer HG. Norepinephrine-induced changes in cardiac TGF-b isoform expression pattern of female and male rats. Hypertension. 2004;410-418.
13. Hunter JJ, Chien KR. Signaling pathways for cardiac hypertrophy and failure. N Engl J Med. 1999;341:1276-1283.
14. Deten A, Holzl A, Leicht M, Barth W, Zimmer HG. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. J Mol Cell Cardiol. 2001;33:1191-1207.
15. Dugina V, Fontao L, Chaponnier C, Vasiliev J, Gabbiani G. Focal adhesion features during myofibroblastic differentiation are controlled by intracellular and extracellular factors. J Cell Sci. 2001;114:3285-3296.
16. Horwitz AR, Parsons JT. Cell migration-movin' on. Science. 1999;286:1102-1103.
17. Brand T, Schneider MD. Transforming growth factor-beta signal transduction. Circ Res. 1996;78:173-179.
18. Petrov VV, Fagard RH, Lijnen PJ. Transforming growth factor-beta(1) induces angiotensin-converting enzyme synthesis in rat cardiac fibroblasts during their differentiation to myofibroblasts. J Renin Angiotensin Aldosterone Syst. 2000;1:342-352.
19. Wrana JL. Regulation of Smad activity. Cell. 2000;100:189-192.
20. Macias Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL. MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 1996;87:1215-1224.
21. Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell. 1998;95:779-791.
22. Moustakas A, Souchelnytskyi S, Heldin CH. Smad regulation in TGF-beta signal transduction. J Cell Scii. 2001;114:4359-4369.
23. Wrana J, Pawson T. Signal transduction. Mad about SMADs. Nature. 1997;388:28-29.
24. Vindevoghel L, Kon A, Lechleider RJ, Uitto J, Roberts AB, Mauviel A. Smad-dependent transcriptional activation of human type VII collagen gene (COL7A1) promoter by transforming growth factor-beta. J Biol Chem. 1998;273:13053-13057.
25. Vindevoghel L, Lechleider RJ, Kon A, de Caestecker MP, Uitto J, Roberts AB, Mauviel A. SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor beta. Proc Natl Acad Sci USA. 1998;95:14769-14774.
26. Hao J, Wang B, Jones SC, Jassal DS, Dixon IM. Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro. Am J Physiol Heart Circ Physiol. 2000;279:H3020-H3030.
27. Akiyama-Uchida Y, Ashizawa N, Ohtsuru A, Seto S, Tsukazaki T, Kikuchi H, Yamashita S, Yano K. Norepinephrine enhances fibrosis mediated by TGF-beta in cardiac fibroblasts. Hypertension. 2002;40:148-154.